Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
United Kingdom·In Vitro Diagnostic Device·Veracyte Inc.·Registered Nov 26, 2024- Device ID
- 148149
- MHRA Reference Number
- 148149
- Date Registered
- Nov 26, 2024
- Last Updated
- Apr 17, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Name
- Veracyte Inc.
- Address
- 6000 Shoreline Court, Suite 300 South San Francisco, CA, United States
- Created Date
- May 23, 2022
- Relationship Type
- UK Responsible Person
- Address
- Compass House, Vision Park Histon c/o Cr360 – UL International Cambridge, England, United KingdomPostcode: CB24 9BZ
Devices with a matching generic name or device type registered with MHRA
Additional devices represented by Emergo Consulting (UK) Limited in the UK
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 148149. The device is manufactured by Veracyte Inc. from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Emergo Consulting (UK) Limited .
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.